TickerFactsScreenerDevelopers

Krystal Biotech, Inc. (KRYS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$9.45M2019: -$18.69M2020: -$26.08M2021: -$47.94M2022: -$100.57M2023: -$88.80M2024: $123.42M2025: $200.87M$200.87M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$200.87M+62.7%
2024$123.42M+239.0%
2023-$88.80M+11.7%
2022-$100.57M-109.8%
2021-$47.94M-83.8%
2020-$26.08M-39.6%
2019-$18.69M-97.9%
2018-$9.45M—